Grous Beth — SEC Form 4 filings
SEC reporting owner CIK 2109144. 1 Form 4 filing on record with FilingPulse; latest filed 2026-03-02.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2026-03-02 to 2026-03-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 300 shares, $4,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: purchase of 300 shares @ $16.00 ($4,800) in Generate Biomedicines, Inc., filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | Chief People Officer | 1 | 1 leg · 300 sh · $4,800 | — | 1 |
Form 4 filings — Grous Beth
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-02 | 4 | Generate Biomedicines, Inc. (GENB) | Purchase (P): 300 @ $16 · Grant/award (A): 114,020 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2109144 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →